Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2026-03-06 @ 4:56 PM
Study NCT ID:
NCT03013218
Status:
COMPLETED
Last Update Posted:
2025-08-01
First Post:
2016-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
Sponsor:
ALX Oncology Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-03
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-08
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-15
First Submit QC Date:
None
Study First Post Date:
2017-01-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-30
Last Update Post Date:
2025-08-01
Last Update Post Date Type:
ACTUAL